CDC20-IN-1 (Compound E1) is a specific inhibitor of CDC20 and can be used in triple-negative breast cancer research. CDC20-IN-1 can induce autophagy in cancer cells and inhibit MDA-MB-231 cell proliferation, with an IC50 value of 1.43 µM[1].
Molecular Weight:
518.78
Formula:
C19H22Cl3N7O4
Target:
Autophagy
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
